Patents by Inventor Ian Chopra

Ian Chopra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Screening Method for Agents Capable of Reversing Fusidic Acid Resistance in Bacteria
    Publication number: 20080118930
    Abstract: A screening method for agents which are capable of reversing resistance to the antibiotic fusidic acid in bacteria that contain the fusB resistance gene or a homologue thereof and that express the FusB fusidic acid resistance protein or a homologue thereof based on the interaction between the fusB resistance protein or a homologue thereof with elongation factor-G (EF-G) protein.
    Type: Application
    Filed: October 14, 2005
    Publication date: May 22, 2008
    Applicant: LEO PHARMA A/S
    Inventors: Ian Chopra, O'Neil Alexander
  • Quinoline-indole antimicrobial agents, uses and compositions related thereto
    Patent number: 6376670
    Abstract: The present invention provides methods and pharmaceutical preparations that inhibit the growth of bacterial microorganisms, via a non-lytic mechanism. Additionally, the present invention provides methods and pharmaceutical preparations that kill bacterial microorganisms, via a non-lytic mechanism.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: April 23, 2002
    Assignee: Sepracor Inc.
    Inventors: Gregory D. Cuny, James R. Hauske, Michael Z. Hoemann, Ian Chopra
  • Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
    Patent number: 6054572
    Abstract: A monoclonal antibody (Mab), or a fragment thereof, that binds to one or more epitopes of a matrix binding protein and an isolated D1-D4 polypeptide from a Staphylococcus aureus Fbp and their use in the prevention of adhesion of bacteria, in particular gram positive bacteria, to extracellular matrix proteins on in-dwelling devices or to matrix proteins in wounds.
    Type: Grant
    Filed: August 3, 1995
    Date of Patent: April 25, 2000
    Assignee: SmithKline Beecham Corporation, p.l.c.
    Inventors: Martin Karl Russel Burnham, Ian Chopra, Ian Alfred Critchley, David Justin Charles Knowles
  • Fibronectin binding protein polypeptides
    Patent number: 5955078
    Abstract: A monoclonal antibody (Mab), or a fragment thereof, that binds to one or more epitopes of a matrix binding protein and an isolated D1-D4 polypeptide (SEQ ID NO. 6, 7, and 8) from a Staphylococcus aureus Fbp and their use in the prevention of adhesion of bacteria, in particular gram positive bacteria, to extracellular matrix proteins on in-dwelling devices or to matrix proteins in wounds.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: September 21, 1999
    Assignee: Smithkline Beecham p.l.c.
    Inventors: Martin Karl Russel Burnham, Ian Chopra, Ian Alfred Critchley, David Justin Charles Knowles